Testing effectiveness (Phase 2)Ended earlyNCT04926324
What this trial is testing
A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers
Who this might be right for
Rectal NeoplasmsRectal Neoplasm Malignant
University of Iowa 3